Venture NAV Tracker / Private company
Long Grove Pharmaceuticals, LLC
Headquarters—
Founded—
Last known round—
Reported valuation—
1 row is omitted from dispersion statistics under the degenerate-mark guard; each affected row states why.
Cross-fund comparison
Current disclosed marks
Included in the same underlying-company comparison band.
| Fund | Security type / annotations | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HRZNHorizon Technology Finance Corp | senior secured loanFair Value — Term LoanNo valuation basis was disclosed for this position. This is an annotation only and does not exclude the mark from comparison statistics.Omitted from statistics — security type is not an eligible fund-equity mark for dispersion. | $10.4MMar 31, 2026 · source ↗ | $10.2MMar 31, 2026 · source ↗ | 98.0%Mar 31, 2026 · source ↗ | Cash rate 7.67%; Index 1-month SOFR; Margin 4.00%; Floor 6.00%Mar 31, 2026 · source ↗ | Feb 27, 2031Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.